2nd oral antiviral for treatment of COVID-19, molnupiravir, receives FDA EUA

NewsDesk @infectiousdiseasenews The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck's molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options [...]

The post 2nd oral antiviral for treatment of COVID-19, molnupiravir, receives FDA EUA appeared first on Outbreak News Today.